Is Compounded Ozempic Safe For Weight Loss? What You Need To Know
Dr. Chris Thompson advises against compounded semaglutide, citing safety concerns and lack of FDA review.
Explore the latest news and coverage about Bariendo
Dr. Chris Thompson advises against compounded semaglutide, citing safety concerns and lack of FDA review.
Dr. Pichamol Jirapinyo and Laurent Kort discussed the effectiveness of calorie counting for weight loss and reviewed various calorie-tracking apps.
HealthCentral covered Gwen Johnson, a Bariendo patient, who chose ESG over costly GLP-1 meds, losing 40 pounds post-procedure.
Dr. Thompson highlights ESG as a more cost-effective and effective weight loss option than semaglutide.
Healthline covered Dr. Christopher Thompson abd Dr. Pichamol Jirapinyo's study on ESG's cost-effectiveness compared to semaglutide such as Wegovy.
Dr. Thompson was quoted by Investor's Business Daily advocating for a more thoughtful approach to using continuous glucose monitors.
Lauren emphasizes balance, moderation, and adding nutritious foods to reduce inflammation and manage weight.
Dr. Christopher Thompson examines the benefits, costs, and risks of different weight-loss treatments.
Dr. Pichamol Jirapinyo highlighted the exclusion of obese individuals from clinical trials and its implications.
Dr. Jirapinyo advises only taking GLP-1 medications under a doctor's supervision and cautions against non-FDA-approved versions.
Dr. Thompson advocates treating obesity as a disease using GLP-1 medications, ESG, and lifestyle changes.
Dr. Thompson explains weight loss plateaus occur when weight remains unchanged for a month despite consistent diet and exercise.